PLRX

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing integrin-based therapeutics. The company aims to understand the role of integrins in various diseases and create therapies that target the underlying molecular mechanisms of these conditions. Pliant operates primarily in the field of drug development, with a focus on creating potentially safer and more effective treatments for patients suffering from serious diseases. Its research and development efforts are directed towards novel therapies that address unmet medical needs across multiple therapeutic areas.